The interactome of transglutaminase-2 in kidney fibrosis : uncovering a mechanism for TG2 unconventional secretion in chronic kidney disease

The interactome of transglutaminase-2 in kidney fibrosis : uncovering a mechanism for TG2 unconventional secretion in chronic kidney disease

Increased release and activity of transglutaminase-2 (TG2) in the tubulointerstitial space has been correlated with the progression of kidney fibrosis during chronic kidney disease (CKD), a condition for which there is no cure. TG2 extracellular activity contributes to kidney fibrosis by determining...

Full description

Bibliographic Details
Main Author:	Furini, Giulia
Published:	Nottingham Trent University 2017
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.728858

Similar Items

Isozyme-specific comprehensive characterization of transglutaminase-crosslinked substrates in kidney fibrosis
by: Hideki Tatsukawa, et al.
Published: (2018-05-01)

Design, synthesis and biological evaluation of TG2 transglutaminase inhibitors
by: Fidalgo Lopez, Javier
Published: (2016)

Spotlight on the Transglutaminase 2-Heparan Sulfate Interaction
by: Giulia Furini, et al.
Published: (2019-01-01)

Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
by: Stefania Martucciello, et al.
Published: (2020-05-01)

Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes.
by: Evgeny A Zemskov, et al.
Published: (2011-04-01)

P3.22 EFFECT OF TISSUE TRANSGLUTAMINASE (TG2) ON CARDIAC AND VASCULAR FUNCTION IN YOUNG TG2 KNOCKOUT MICE
by: K.D. Viegas, et al.
Published: (2012-11-01)

Unraveling the Secrets of Kidney Disease: Novel Molecular Mechanisms of Acute and Chronic Kidney Injury
by: Rudomanova, Valeriia
Published: (2021)

Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
by: Kapil Mehta, et al.
Published: (2011-02-01)

Transglutaminase 2 in chronic kidney disease of the domestic feline and its role in a rodent model of renal warm ischaemia
by: Sánchez Lara, Armando Cristian
Published: (2015)

Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN
by: Wang Yi, et al.
Published: (2012-07-01)

Original Article Diagnosis of Oral Cancer by Transglutaminase 2 (TG-2) Expression and its Clinical Significance
by: Elva Lim, et al.
Published: (2017)

Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line
by: Xiaoxue Yin, et al.
Published: (2012-08-01)

Tissue transglutaminase (TG2) activity regulates osteoblast differentiation and mineralization in the SAOS-2 cell line
by: Xiaoxue Yin, et al.
Published: (2012-08-01)

Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
by: Sara Panizo, et al.
Published: (2021-01-01)

Tissue Transglutaminase (TG2) is a potential therapeutic target in the treatment of chemoresistant breast cancer
by: Rajasekaran, Vidya
Published: (2014)

Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
by: Jesús Rivero, et al.
Published: (2020-03-01)

The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease.
by: Anne-Cecile Huby, et al.
Published: (2012-01-01)

Organization of physical interactomes as uncovered by network schemas.
by: Eric Banks, et al.
Published: (2008-10-01)

Role of Transglutaminase 2 in Cell Death, Survival, and Fibrosis
by: Hideki Tatsukawa, et al.
Published: (2021-07-01)

Unconventional functions of mitotic kinases in kidney tumourigenesis
by: Pauline eHascoet, et al.
Published: (2015-10-01)

Kidney ACE2 expression: Implications for chronic kidney disease.
by: Nicholas Maksimowski, et al.
Published: (2020-01-01)

Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System
by: Yaghoub Yazdani, et al.
Published: (2016-03-01)

Urinary Extracellular Vesicles: Uncovering the Basis of the Pathological Processes in Kidney-Related Diseases
by: Giulia Cricrì, et al.
Published: (2021-06-01)

SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
by: Swetha R. Kanduri, et al.
Published: (2020-08-01)

Chronic kidney disease and fibrosis: the role of uremic retention solutes
by: Henricus A.M. Mutsaers, et al.
Published: (2015-08-01)

Constitutive secretion of tau protein by an unconventional mechanism
by: Xiyun Chai, et al.
Published: (2012-12-01)

MMP-2 and 9 in Chronic Kidney Disease
by: Zhengyuan Cheng, et al.
Published: (2017-04-01)

Contribution of uremic toxins to the vascular fibrosis associated with chronic kidney disease
by: Marco Hatem-Vaquero, et al.
Published: (2018-11-01)

Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
by: Ashraf, U.M, et al.
Published: (2022)

Combating Kidney Fibrosis
by: Keizo Kanasaki, et al.
Published: (2014-01-01)

Transglutaminase 2 in human diseases
by: Szondy Zsuzsa, et al.
Published: (2017-09-01)

Secretion of Tau via an Unconventional Non-vesicular Mechanism
by: Maria Merezhko, et al.
Published: (2018-11-01)

Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population
by: Jia Wen, et al.
Published: (2017-12-01)

Role of Akt1 in renal fibrosis and tubular dedifferentiation during the progression of acute kidney injury to chronic kidney disease
by: Il Young Kim, et al.
Published: (2021-07-01)

The Roles of Kidney-Resident ILC2 in Renal Inflammation and Fibrosis
by: Ryuichi Nagashima, et al.
Published: (2021-07-01)

Optimization of chronic kidney disease stages in patients with type 2 diabetes mellitus with the program "ChronicKidneyDiseaseDiagnostics"
by: Yarkova N.A., et al.
Published: (2017-09-01)

NONSPECIFIC MECHANISMS OF CHRONIC KIDNEY DISEASE PROGRESSION
by: V. V. Kalyuzhin, et al.
Published: (2015-08-01)

Editorial: Molecular Mechanisms in Chronic Kidney Disease
by: Claudia Torino, et al.
Published: (2021-06-01)

Chronic Kidney Disease: Underlying Molecular Mechanisms
Published: (2023)

Management of type 2 diabetes in chronic kidney disease
by: Salim S Virani, et al.
Published: (2021-08-01)